The Chemours Company, LLC:戦略・SWOT・企業財務分析

◆英語タイトル:The Chemours Company, LLC - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA8014612
◆発行会社(調査会社):MarketLine
◆発行日:2017年11月11日
◆ページ数:43
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:化学・材料
◆販売価格オプション(消費税別)
Single UserUSD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

The Chemours Company, LLC – Strategy, SWOT and Corporate Finance Report
Summary

The Chemours Company, LLC – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

The Chemours Company, LLC (Chemours) is a chemical company that offers performance chemicals. It provides ingredients for plastics and coatings, mining and oil refining operations, refrigeration and air conditioning, and general industrial manufacturing. The company sells its products through Ti-Pure, Opteon, Krytox, Teflon, Viton, Freon, and Nafion brands. Chemours serves architectural and industrial coatings, plastic packaging, laminate papers, coated paper and coated paperboard, automotive, pipe lining and gaskets, network cables, gold production, water treatment, oil and gas, electronics, automotive, and other industries across North America, Asia Pacific, Europe, the Middle East, Africa, and Latin America. The company has production facilities in the US, Mexico, and Taiwan; repackaging and distribution facility in Belgium; and a mineral sands mining facility in the US. Chemours is headquartered in Wilmington, Delaware, the US.

Scope

- Detailed information on The Chemours Company, LLC required for business and competitor intelligence needs
- A study of the major internal and external factors affecting The Chemours Company, LLC in the form of a SWOT analysis
- An in-depth view of the business model of The Chemours Company, LLC including a breakdown and examination of key business segments
- Intelligence on The Chemours Company, LLC’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about The Chemours Company, LLC, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of The Chemours Company, LLC and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess The Chemours Company, LLC as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on The Chemours Company, LLC’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
The Chemours Company, LLC: Company Overview
The Chemours Company, LLC: Overview and Key Facts
The Chemours Company, LLC: Overview
The Chemours Company, LLC: Key Facts
The Chemours Company, LLC: Key Employees
The Chemours Company, LLC: Key Employee Biographies
The Chemours Company, LLC: Major Products and Services
The Chemours Company, LLC: Company History
The Chemours Company, LLC: Management Statement
The Chemours Company, LLC: Locations and Subsidiaries
The Chemours Company, LLC: Key Competitors
The Chemours Company, LLC: Company Analysis
The Chemours Company, LLC: Business Description
The Chemours Company, LLC: SWOT Analysis
The Chemours Company, LLC: SWOT Overview
The Chemours Company, LLC: Strengths
The Chemours Company, LLC: Weaknesses
The Chemours Company, LLC: Opportunities
The Chemours Company, LLC: Threats
The Chemours Company, LLC: Corporate Financial Deals Activity
The Chemours Company, LLC: Financial Deals Overview
The Chemours Company, LLC: Top Deals 2013 – 2017YTD*
The Chemours Company, LLC: Advisors
The Chemours Company, LLC: Top Legal Advisors
The Chemours Company, LLC: Top Financial Advisors
The Chemours Company, LLC: Capital Raising
The Chemours Company, LLC: Divestments
The Chemours Company, LLC: Recent Developments
The Chemours Company, LLC: News and Events Summary
The Chemours Company, LLC: Business Expansion
The Chemours Company, LLC: Contracts
The Chemours Company, LLC: Financial Performance
The Chemours Company, LLC: Red Flags/DistressSignals
The Chemours Company, LLC: Regulatory and Legal Events
The Chemours Company, LLC: Strategy and Operations
Appendix
Contact Us
Methodology
Definitions
About MarketLine

List of Tables
Table 1: The Chemours Company, LLC: Key Facts
Table 2: The Chemours Company, LLC: Key Employees
Table 3: The Chemours Company, LLC: Locations and Subsidiaries
Table 4: The Chemours Company, LLC: Key Competitors
Table 5: The Chemours Company, LLC: Deal Activity by Deal Type - Volume (TTM*)
Table 6: The Chemours Company, LLC: Deal Activity by Deal Type - Volume (2013 - YTD*2017)
Table 7: The Chemours Company, LLC: Top Deals 2013 - 2017YTD*
Table 8: The Chemours Company, LLC: Legal Advisor Ranking by Value (US$m)
Table 9: The Chemours Company, LLC: Financial Advisor Ranking by Value (US$m)
Table 10: The Chemours Company, LLC: Capital Raising Volume and Value Trend (2013 - YTD*2017)
Table 11: The Chemours Company, LLC: Capital Raising by Deal Type (2013 - YTD*2017)
Table 12: The Chemours Company, LLC: Divestments Volume and Value Trend (2013 - YTD*2017)
Table 13: The Chemours Company, LLC: Divestments by Geography (2013 - YTD*2017)
Table 14: The Chemours Company, LLC: News and Events Summary
Table 15: The Chemours Company, LLC: Business Expansion
Table 16: The Chemours Company, LLC: Contracts
Table 17: The Chemours Company, LLC: Financial Performance
Table 18: The Chemours Company, LLC: Red Flags/DistressSignals
Table 19: The Chemours Company, LLC: Regulatory and Legal Events
Table 20: The Chemours Company, LLC: Strategy and Operations

★海外企業調査レポート[The Chemours Company, LLC:戦略・SWOT・企業財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Cox & Kings Limited:企業の戦略・SWOT・財務分析
    Cox & Kings Limited - Strategy, SWOT and Corporate Finance Report Summary Cox & Kings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • CSG Systems International Inc (CSGS):企業の財務・戦略的SWOT分析
    CSG Systems International Inc (CSGS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Eli Lilly and Co (LLY)-医療機器分野:企業M&A・提携分析
    Summary Eli Lilly and Company (Lilly) is a healthcare company that discovers, develops and markets human and animal healthcare products. The company offers medicines for cardiovascular conditions, diabetes, cancer, neurological problems, critical care, men's health and musculoskeletal problems. It a …
  • Mindax Limited:企業の戦略・SWOT・財務情報
    Mindax Limited - Strategy, SWOT and Corporate Finance Report Summary Mindax Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Heidelberger Druckmaschinen AG:企業の戦略・SWOT・財務分析
    Heidelberger Druckmaschinen AG - Strategy, SWOT and Corporate Finance Report Summary Heidelberger Druckmaschinen AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • EyePoint Pharmaceuticals Inc (PSDV):製薬・医療:M&Aディール及び事業提携情報
    Summary EyePoint Pharmaceuticals Inc (EyePoint), formerly pSivida Corp, is a biopharmaceutical company that provides development of miniaturized, sustained-release drug delivery products and technologies. The company offers products such as iluvien, retisert and durasert, among others. Its durasert …
  • Bank Of Cyprus Public Company Ltd:企業の戦略・SWOT・財務分析
    Bank Of Cyprus Public Company Ltd - Strategy, SWOT and Corporate Finance Report Summary Bank Of Cyprus Public Company Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Moog Inc.:企業の戦略・SWOT・財務情報
    Moog Inc. - Strategy, SWOT and Corporate Finance Report Summary Moog Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Oncodesign SA (ALONC):企業の財務・戦略的SWOT分析
    Summary Oncodesign SA (Oncodesign) is a biopharmaceutical company, specializing in precision medicine offers drug discovery and pharmacological evaluation services for cancer. Its service offerings include integrated drug discovery; metabolic and pharmacokinetic characteristics of chemical and biolo …
  • CBRE Global Investors LLC:企業の戦略的SWOT分析
    CBRE Global Investors LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Takeda Pharmaceutical Company Limited:企業のM&A・事業提携・投資動向
    Takeda Pharmaceutical Company Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Takeda Pharmaceutical Company Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed report …
  • The Royal Bank of Scotland Group Plc:企業の戦略・SWOT・財務情報
    The Royal Bank of Scotland Group Plc - Strategy, SWOT and Corporate Finance Report Summary The Royal Bank of Scotland Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Lentigen Technology Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Lentigen Technology Inc (Lentigen), a subsidiary of Miltenyi Biotec GmbH, is a provider of gene delivery and expression technology solutions. The company provides clinical trial support in viral vector product development and clinical applications, among others. Its lentiviral vectors finds …
  • Zebra Technologies Corp (ZBRA):企業の財務・戦略的SWOT分析
    Zebra Technologies Corp (ZBRA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • TriVascular Inc:製品パイプライン分析
    Summary TriVascular Inc (TriVascular), a subsidiary of Endologix Inc is a medical device company that researches, designs and manufactures technologies to provide optimal solutions for endovascular aortic repair. The company’s product comprise endovascular grafts and self-expanding stent grafts; ova …
  • Petrolia SE (PDR):企業の財務・戦略的SWOT分析
    Summary Petrolia SE (Petrolia), formerly Petrolia E&P Holdings SE is an oil and gas company that offers well technology solutions. The company operates through two segments such as exploration and production (E&P), and oil service segments. Its E&P’s segment seeks to maximise field potential through …
  • El Al Israel Airlines Ltd.:企業の戦略・SWOT・財務情報
    El Al Israel Airlines Ltd. - Strategy, SWOT and Corporate Finance Report Summary El Al Israel Airlines Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • VT Holdings Co Ltd (7593):企業の財務・戦略的SWOT分析
    VT Holdings Co Ltd (7593) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Translate Bio Inc (TBIO):製薬・医療:M&Aディール及び事業提携情報
    Summary Translate Bio Inc (Translate Bio), formerly RaNA Therapeutics Inc is a healthcare service provider that develops therapies which targets RNA within cells in the body to selectively activate protein expression. The company provides platform oligonucleotides (oligos) are molecules designed to …
  • Mangalam Drugs and Organics Ltd (MANGALAM):企業の財務・戦略的SWOT分析
    Summary Mangalam Drugs and Organics Ltd (MDOL) is a chemical manufacturing company that manufactures, develops, and supplies specialty chemicals, intermediates, and active pharmaceutical ingredients. The company's active pharmaceutical ingredients include amodiaquine HCl, bisoprolol fumarate, chloro …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆